Response to the letter to the editor-'Amiodarone-induced phlebitis: incidence and adherence to a clinical practice guideline' by Jafari et al

Eur J Cardiovasc Nurs. 2023 Dec 14;22(8):e135-e136. doi: 10.1093/eurjcn/zvad058.

Authors

Gunhild Brørs¹, Kari Hanne Gjeilo^{1

2}, Ole Christian Mjølstad^{1

3}

Affiliations

¹ Clinic of Cardiology, St. Olavs hospital, Trondheim University Hospital, Prinsesse Kristinas gate 3, 7030 Trondheim, Norway.
² Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
³ Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.

PMID: 37337672
DOI: 10.1093/eurjcn/zvad058

No abstract available

Publication types

Comment

MeSH terms

Amiodarone*
Anti-Arrhythmia Agents / adverse effects
Humans
Incidence
Phlebitis* / chemically induced
Phlebitis* / epidemiology

Substances

Amiodarone
Anti-Arrhythmia Agents